TRUALT Q3 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹713 Cr
verified against source
Revenue YoY
13.28%
reported change
EBITDA
Pending
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
TruAlt Bioenergy reported 9-month total income of 1,187 crore, up 13.28% YoY, with PAT of 35.92 crore growing 2.8% despite Q3 operational disruptions. The ethanol segment faced headwinds—Karnataka farmer protests and delayed grain-based plant commissioning limited Q3 operations to ~58 operating days, resulting in only 7.6 crore liters volume. However, all five ethanol plants are now fully operational, targeting 90-95% capacity utilization in Q4 FY26. The CBG segment demonstrated strong execution with 63% EBITDA margin and 43% PAT margin for 9M, validating the operating model ahead of the 24-plant expansion through GAIL and Sumitomo JVs. The proposed 100 million liter SAF facility in Andhra Pradesh (₹2,000 crore capex, 22-25% EBITDA target) positions the company ahead of India's emerging SAF mandate. Key risks include Q4 ramp-up execution, delayed policy clarity on ethanol pricing for private OMCs, and feedstock cost volatility impacting DDGS economics.
Colored figures show movement against the previous available record.
Guidance to track
- All five ethanol plants fully operational; targeting optimum 5.5-6 crore liters monthly production as utilization normalizes from partial Q3 performance.
- Revised downward from earlier 41 crore liters projection due to Q2 complete shutdown and Q3 disruptions from Karnataka farmer protests and delayed grain-based plant commissioning.
- Four new CBG plants (80 TPD total) under Sumitomo JV scheduled to commission by June-July 2026; five GAIL plants (100 TPD total) to follow after February equity infusion.
- Targeting 180-200 rupees per liter realization with 22-25% EBITDA margin; ₹2,000 crore capex with ₹150 crore PMG1 viability gap funding expected; commissioning targeted July-October 2027.
Risks flagged
- India's SAF blending mandate (1% from FY27, 2% by FY28, 5% by 2030) faces potential delays in policy framework finalization; global CORSIA enforcement effectiveness remains uncertain pending government approach.
- High Court granted 90-day extension to fulfill 1,075 crore contracted ethanol supply shortfall from supply year ending October 2025; OMC lifting entirely within extended timeline remains subject to negotiation dynamics.
- Recent US trade deal allows DDGS imports up to 5 lakh metric tons, potentially pressuring domestic DDGS prices from current 15-35 rupees per kg range toward 22-26 rupees per kg.
- Total planned capex of ₹1,650 crore for CBG (24 plants) and ₹2,000 crore for SAF requires significant capital deployment, GAIL JV formalization, and multiple regulatory approvals within compressed timelines.
Key quotes
- Our investment strategy is not in the expectation that tomorrow government will come with a policy. Our investment strategy is structured based on offtake guarantees before we commit on ground investments.
- The company has absorbed the full fixed cost of entire 9 months but the revenue was in proportion booked only for the partial period of 48 to 50 days impacting the margin maintained by the company.
- Ethanol you have seen it's peaked out. So let's say at 6 crore liters per month... CBG business we are setting up 24 plants... in SAF we are looking at an EBITDA of somewhere between 22 to 25% that's our target to achieve.
Research modules